Tyrosine Kinase/Adaptors
Tyrosine kinase and adaptor inhibitors are compounds that target tyrosine kinases and their associated adaptor proteins, which play pivotal roles in cell signaling, growth, and differentiation. These inhibitors are essential tools in cancer research, as many tyrosine kinases are involved in the signaling pathways that drive tumor growth and metastasis. By inhibiting tyrosine kinases, these compounds can block critical signaling cascades, offering potential therapeutic strategies for various cancers and other diseases involving abnormal cell signaling. At CymitQuimica, we provide a comprehensive range of high-quality tyrosine kinase and adaptor inhibitors to support your research in oncology, molecular biology, and targeted therapy development.
Read more
Subcategories of "Tyrosine Kinase/Adaptors"
ALK
CSF-1R
EGFR
Ephrin Receptor
FLT
Fibroblast Growth Factor Receptor (FGFR)
HER
Hck
IGF-1R
PDGFR
PYK2
Src
TAM Receptor
Tie-2
Trk receptor
Tyrosine Kinases
VEGFR
c-Fms
c-Kit
c-Met/HGFR
c-RET
Show 13 more subcategories
Products of "Tyrosine Kinase/Adaptors"
Ganitumab
CAS:905703-97-1
Ganitumab (AMG 479) is a potent monoclonal antibody targeting IGF1R with 0.22 nM affinity; used …
Purity:
100% (SEC-HPLC) - > 95%
Color and Shape:
Liquid
Molecular weight:
145.70 kDa
Ref: TM-T76810
| 1mg | 269.00 € | ||
| 5mg | 702.00 € | ||
| 10mg | 1,096.00 € | ||
| 25mg | 1,654.00 € | ||
| 50mg | 2,220.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Rilotumumab
CAS:872514-65-3
Rilotumumab (AMG 102) is an HGF-targeting antibody, inhibits HGF/MET signaling, and is used for CRPC …
Purity:
SDS-PAGE:95% SEC-HPLC:97.51%
Color and Shape:
Liquid
Molecular weight:
145.2 kDa
Ref: TM-T76758
| 1mg | 237.00 € | ||
| 5mg | 620.00 € | ||
| 10mg | 993.00 € | ||
| 25mg | 1,476.00 € | ||
| 50mg | 1,977.00 € | ||
| 100mg | 2,673.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Ascrinvacumab
CAS:1463459-96-2
Ascrinvacumab (PF-03446962): humanized IgG2 anti-ALK-1 antibody, Kd 7 nM, inhibits TGF-β, for HCC research.
Purity:
SDS-PAGE:95% SEC-HPLC:98.18%
Color and Shape:
Liquid
Molecular weight:
150 kDa
Ref: TM-T76858
| 1mg | 230.00 € | ||
| 5mg | 601.00 € | ||
| 10mg | 916.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Emibetuzumab
CAS:1365287-97-3
Emibetuzumab: potent humanized MET antibody, antitumor, inhibits HGF/MET pathways, for advanced prostate cancer research.
Purity:
SDS-PAGE:96.2%;SEC-HPLC:98.8%
Color and Shape:
Liquid
Molecular weight:
143.74 kDa
Ref: TM-T76743
| 1mg | 142.00 € | ||
| 5mg | 416.00 € | ||
| 10mg | 662.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Olaratumab
CAS:1024603-93-7
Olaratumab(IMC-3G3) is a human monoclonal IgG1 antibody against platelet-derived growth factor receptor alpha (PDGFRα), which …
Purity:
SDS-PAGE:95% SEC-HPLC:98.70%
Color and Shape:
Liquid
Molecular weight:
147.12 kDa
Ref: TM-T76761
| 1mg | 230.00 € | ||
| 5mg | 599.00 € | ||
| 10mg | 916.00 € | ||
| 25mg | 1,420.00 € | ||
| 50mg | 1,837.00 € | ||
| 100mg | 2,588.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
LMTK3-IN-1
CAS:2764850-23-7
Lmtk3-in-1 is a potent ATP-competitive lemur tyrosine kinase 3 (LMTK3) (Kd=2.5 μM) inhibitor that degrades …
Formula:
C18H11F3N4O
Purity:
100%
Color and Shape:
Soild
Molecular weight:
356.3
Ref: TM-T77620
| 1mg | 52.00 € | ||
| 5mg | 109.00 € | ||
| 10mg | 171.00 € | ||
| 25mg | 276.00 € | ||
| 50mg | 421.00 € | ||
| 100mg | 609.00 € | ||
| 500mg | 1,263.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Petosemtamab
CAS:2213450-26-9
Petosemtamab (MCLA 158), a dual-action monoclonal antibody targets EGFR & LGR5, used in solid tumor …
Purity:
> 95% - > 95%
Color and Shape:
Liquid
Molecular weight:
145.97 kDa
Ref: TM-T76890
| 1mg | 332.00 € | ||
| 5mg | 862.00 € | ||
| 10mg | 1,392.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Bemarituzumab
CAS:1952272-74-0
Bemarituzumab: humanized IgG1 antibody inhibits FGFR2b, may be used in cancer research.
Purity:
SDS-PAGE:95% SEC-HPLC:99.99%
Color and Shape:
Liquid
Molecular weight:
144 kDa
Ref: TM-T76673
| 1mg | 185.00 € | ||
| 5mg | 502.00 € | ||
| 10mg | 802.00 € | ||
| 25mg | 1,203.00 € | ||
| 50mg | 1,633.00 € | ||
| 100mg | 2,219.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Otilimab
CAS:1638332-55-4
Otilimab, a humanized monoclonal antibody, blocks GM-CSF to reduce inflammation and may treat severe COVID-19 …
Purity:
> 95%
Color and Shape:
Liquid
Molecular weight:
142.22 kDa
Ref: TM-T77125
| 1mg | 118.00 € | ||
| 5mg | 299.00 € | ||
| 10mg | 512.00 € | ||
| 25mg | 811.00 € | ||
| 50mg | 1,086.00 € | ||
| 100mg | 1,473.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
ROS-generating agent 1
CAS:2369030-41-9
Ros-generating agent 1 has anticancer activity and generates ROS by covalently modifying Sec-498 residues of …
Formula:
C21H15F6NO
Purity:
99.67%
Color and Shape:
Soild
Molecular weight:
411.34
Ref: TM-T77762
| 1mg | 36.00 € | ||
| 5mg | 78.00 € | ||
| 10mg | 118.00 € | ||
| 25mg | 184.00 € | ||
| 50mg | 348.00 € | ||
| 100mg | 581.00 € | ||
| 500mg | 1,188.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Aprutumab
CAS:1634620-63-5
Aprutumab, a human FGFR2 monoclonal antibody, targets FGFR2-IIIB/C and is used in antibody-drug conjugates.
Purity:
98.69% (SEC-HPLC) - 98.69% (SEC-HPLC)
Color and Shape:
Liquid
Molecular weight:
150 kDa
Ref: TM-T76672
| 1mg | 531.00 € | ||
| 5mg | 1,505.00 € | ||
| 10mg | 2,025.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
(S)-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-2-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-7-carboxamide
CAS:1934246-20-4
MitoBloCK-6 is an effective inhibitor of Erv1/ALR with IC50 values of 900 nM and 700 …
Formula:
C26H23F3N6O
Purity:
99.87%
Color and Shape:
Soild
Molecular weight:
492.5
Ref: TM-T60186
| 1mg | 113.00 € | ||
| 2mg | 169.00 € | ||
| 5mg | 250.00 € | ||
| 10mg | 367.00 € | ||
| 25mg | 550.00 € | ||
| 50mg | 775.00 € | ||
| 100mg | To inquire | ||
| 1mL*10mM (DMSO) | 303.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
ALW-II-49-7
CAS:1135219-23-6
ALW-II-49-7 is a selective and potent inhibitor of EphB2 kinase with an EC50 value of …
Formula:
C21H17F3N4O2
Purity:
99.84%
Color and Shape:
Soild
Molecular weight:
414.38
Ref: TM-T67736
| 1mg | 70.00 € | ||
| 5mg | 164.00 € | ||
| 10mg | 238.00 € | ||
| 25mg | 432.00 € | ||
| 50mg | 636.00 € | ||
| 100mg | 900.00 € | ||
| 500mg | 1,811.00 € | ||
| 1mL*10mM (DMSO) | 175.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
JAK1/2/3 Inhibitor 1
CAS:16234-14-3
JAK1/2/3 Inhibitor 1 is a potent protein kinase inhibitor.JAK1/2/3 Inhibitor 1 has antitumor activity that …
Formula:
C6H2Cl2N2S
Purity:
99.32%
Color and Shape:
Liquid
Molecular weight:
205.06
Ref: TM-T77504
| 5mg | 54.00 € | ||
| 10mg | 64.00 € | ||
| 25mg | 96.00 € | ||
| 50mg | 123.00 € | ||
| 100mg | 176.00 € | ||
| 500mg | 474.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Naluzotan hydrochloride
CAS:740873-82-9
Naluzotan hydrochloride, a hERG K+ blocker (IC50: 3800 nM) and potent 5-HT1A agonist (IC50: ~20 …
Formula:
C23H39ClN4O3S
Purity:
98.61%
Color and Shape:
Liquid
Molecular weight:
487.1
Ref: TM-T68113
| 1mg | 215.00 € | ||
| 5mg | 530.00 € | ||
| 10mg | 759.00 € | ||
| 25mg | 1,168.00 € | ||
| 50mg | 1,559.00 € | ||
| 100mg | 2,116.00 € | ||
| 500mg | 4,241.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
JAK3-IN-15
JAK3-IN-15 (compound 22) is a JAK3 inhibitor that reduces the secretion of p-JAK3 induced by …
Ref: TM-T200631
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
Depatuxizumab MMAF
Depatuxizumab-MMAF, an antibody-drug conjugate (ADC), comprises an EGFR-targeted antibody linked to McMMAF and is utilized …
Color and Shape:
Liquid
Molecular weight:
148.24 kDa
Ref: TM-T9901A-197
| 1mg | To inquire | ||
| 5mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
VEGFR-2-IN-55
VEGFR-2-IN-55 (Compound 30) is an effective VEGFR-2 kinase inhibitor with an IC50 of 1.24 nM …
Ref: TM-T200578
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
DS06652923
DS06652923 is an orally active inhibitor targeting EGFR triple mutations. It exhibits growth-inhibitory effects on …
Ref: TM-T200714
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
Antiproliferative agent-57
Antiproliferative agent-57 (compound M2) is a tumor angiogenesis inhibitor that suppresses VEGF secretion in SiHa …
Ref: TM-T200522
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
